Fact CheckerSign in

NCT07883070Recruiting

Anxiety and Depression in Patients With Hematologic Malignancies

An Observational Prospective Cohort Study of Anxiety and Depression in Patients With Hematologic Malignancies

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
2 Aug 2026
Start date
20 Oct 2026
Primary completion date
1 Dec 2030
Lead sponsor
The First Affiliated Hospital of Xiamen University
NCT number
NCT07883070

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 20 Oct 2026 to the primary completion date, 1 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\. Patients with any other conditions considered by the investigator to be inappropriate for participation in this study.

Who the study is looking for

  • Patients with hematologic malignancies who visit the Department of Hematology at the First Affiliated Hospital of Xiamen University from August 2026 onward, including lymphoma, multiple myeloma, and leukemia.
  • Patients who are able to understand and voluntarily participate in anxiety and depression status assessments.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
the First Affilaited Hospital of Xiamen University
Coordinator of this site? Confirm its status		XiamenChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.